Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

1st woman on SCOTUS dies
Thanks Murray for support
Publicist debunks rumors
Ex-husband ordered to repay
$2.6M for body cameras
Ex-Marine pleads guilty
Performed Heimlich maneuver
$2.7B for climate projects
Von Miller turns himself in
Salmonella outbreak risk
To revamp burger patties
Sexual battery probe
'Cannibal' solar burst
Supports ‘Renaissance’ film
Judge halts MT TikTok ban
President's campaign leave
The National Christmas Tree
Pre-trial detention extended
Pistons 16th straight loss
Drops twice-daily obesity pill
Mets sign Austin Adams
Joey Wendle's 1-year deal
'RU war is in a new phase'
Firearm suicide rates up 11%
OPEC+ cuts oil production
Red Sea Film Festival
Hands out his final rose
‘It's time to come back’
'Thanksgiving 2' in the works
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
325,000 results
3d
What To Know About Metformin: The Decades-Old Diabetes Drug Fueling Billions in Longevity Research
American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...
朝日新聞社11d
US approves Alzheimer’s drug that modestly slows disease
FDA approves much-debated Alzheimer’s drug panned by experts June 8, 2021 Alzheimer’s drug from Eisai and Biogen slows cognitive decline, side-effects in focus November 30, 2022 Panel: More ...
Forbes15d
Is The Alzheimer’s Drug Leqembi Eligible For Medicare Coverage?
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.
Hosted on MSN17d
Tirzepatide gets FDA approval for weight loss
There's a new weight loss drug that has been given FDA approval. Dr. Mike Cirigliano talks about it. Trump posts ‘Thanksgiving message’ at 2 a.m. with a list of insults NASA Warns Solar Storm ...
4d
BrainSpec Receives Full FDA Clearance to Begin Using AI-Backed Solution for Non-Invasive Brain Chemistry Measurement
BrainSpec, the comprehensive software platform enabling virtual biopsies of the brain, has been awarded clearance by the FDA to begin using their Magnetic Resonance Spectroscopy (MRS) platform to ...
WTSP24d
New research at USF Health could lead to breakthrough in treating Alzheimer's
TAMPA, Fla. — November is Alzheimer's Awareness Month. It's estimated that 1 in 8 Floridians are currently living with the disease and are supported by more than 800,000 unpaid family caregivers.
1d
FDA supports new research to develop anti-aging drugs for large breed dogs
A new era in medicine to further the life expectance in larger dog breeds is on the horizon with FDA support, according to ...
1d
Defying fate, woman with early-onset Alzheimer’s gene joins new drug trial at Park Ridge hospital
Heather Mejia, 44, learned she carried a gene for early onset Alzheimer's disease and enrolled in a clinical trial at ...
RealClearMarkets15d
The FDA Is Too Aggressive About Blocking Life-Saving Drugs
When my friend Ira was diagnosed with Pancreatic cancer he went through surgery and chemotherapy, but was still facing a short life expectancy. Then he was lucky to be 1 of only 26 patients in an ...
12don MSN
Doubts abound about a new Alzheimer’s blood test
A new poll from the University of Michigan confirms that older adults will take results seriously: Ninety-seven percent of ...
The Business Journals21d
Lab Notes: Cabaletta Bio gets FDA nod to advance new drug; South Jersey firm raises $3.5M
This week's Lab Notes has items on a multimillion-dollar debt financing, a manufacturing deal, a new director hire at CHOP, a positive study for a medical device and more. Here’s the roundup ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices